Prostate cancer tutorial Flashcards
(29 cards)
Epidemiology of prostate cancer in males in UK
most common cancer in UK males. 2nd mortality after lung cancer. Has had an increasing incidence
Causes of prostate cancer
hetergoeneous, environments and genetics
Hypotheses for cause of familial (genetic) prostate cancer
PTEN (tumour suppressor gene) inactivation leading to autonomous activation of androgen receptor (shown to antagonise androgen receptor signalling pathway) or facilitates anti-apoptotic pathways
Clinical presentation of prostate cancer
Problems urinating
less common lower back pain and haematuria
Normal physiological role of prostate gland
exocrine gland, production of seminal fluid released into prostatic part of urethre, component of ejaculate, necessary for male fertility
frequent sites of metastasis of prostate cancer
seminal vesicles, bladder
lymph nodes and bones
What is PSA?
Prostate specific antigen
describe and explain Normal PSA levels in blood
Normally undetectable PSA due to inability to pass through gap junctions/BM of luminal ep cells of prostate
Describe and explain PSA levels in prostate cancer/BPH
Elevated due to hyperplasia and leakage into blood so detectable (cancer usually grows disorganised so lack of junction/invasion past BM)
WHat is BPH? Who does usually affect?
Benign prostatic hyperplasia
Hyperplasia of prostate gland not associated with malignancy
Most >50y males
What is the cut off for PSA above which further investigation need to be conducted?
4ng/ml serum
Reasons for elevated PSA not cancer
bike riding, exercise, UTI, post-biopsy, prostatitis, anal sex
Tests done after +ve elevated PSA
biopsy and tumour grading, digital rectal exam, MRI scan
Scoring system used to grade prostate cancers
Gleason score
Nature of prostate cancers
slow-growing “pussycats” or aggressive “tigers” and life-threatening due to throwing off metastases that usually cause bone involvement
“treatment” for low grade/slow growing prostate malignant cancer
nothing, watchful waiting by doing regular tests
Treatments of prostate cancers confined to prostate gland exclusively
Radical prostatectomy surgery (highest survival PSA<10-12ng/ml and <70yo)
Targeted external beam radiotherapy
Brachytherapy = implantation of radioactive seeds into prostate
SE of prostatectomy/radiotherapy/brachytherapy
inontinence, pudendal nerve damage -> impotence
Principle for hormone therapy in prostate cancer
Androgens stimulate prostatic growth via androgen receptor, so can be used to halt tumour progression/growth
Treatment options in hormone therapy and explanation
Chemical bilateral orchidectomy causing most androgen production to cease
Anti-androgens
Mechanism of Chemical bilateral orchidectomy
LHRH agonist used
Causes desenitisation of pituiatry gonadotrophs, so LH production ceases and testosterone/androgen prod also ceases
MOA of antiandogens
Androgen receptor antagonists
SE of hormone therapy
osteoporosis, loss of libido, muscle atrophy, memory loss, gynaecomastia
Explain androgen independence in prostate tumours after effective hormone therapy
Prostate cancers can become symptomatic and usually more aggressive after hormone therapy